TIZONA
Dead / Abandoned — Abandoned — no statement of use filed (as of 30 Jan 2019)
What this means for you
This application is over — abandoned 30 Jan 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86658128
- Mark type
- Stylized text
- Filed
- 10 Jun 2015
- Published for opposition
- 03 Nov 2015
- Abandoned
- 30 Jan 2019
- Attorney of record
- Sharon Smith
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in the treatment of cancer and autoimmune diseases; pharmaceutical preparations and compounds for modulation of the immune system and the tumor microenvironment
- Class 042 — Scientific and technological services: consulting services in the field of pharmaceutical research and development; research and development of pharmaceutical preparations and medicines for others
Owner
- TIZONA THERAPEUTICS, INC., CAMBRIDGE, MA, US
- Vesuvius Pharmaceuticals, Inc., Cambridge, MA, US
- Vesuvius Pharmaceuticals, Inc., Cambridge, MA, US
Prosecution history
- 31 Jan 2019 — CORRECTED NOA E-MAILED
- 30 Jan 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 30 Jan 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 30 Jan 2019 — DIVISIONAL PROCESSING COMPLETE
- 26 Dec 2018 — DIVISIONAL REQUEST RECEIVED
- 14 Jan 2019 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jan 2019 — ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
- 26 Dec 2018 — TEAS REQUEST TO DIVIDE RECEIVED
- 03 Jul 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Jul 2018 — SOU EXTENSION 5 GRANTED
- 29 Jun 2018 — SOU EXTENSION 5 FILED
- 29 Jun 2018 — SOU TEAS EXTENSION RECEIVED
- 31 Jan 2018 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2018 — SOU EXTENSION 4 GRANTED
- 29 Dec 2017 — SOU EXTENSION 4 FILED